Cas 254745-48-7,2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester

254745-48-7

Post Buying Request

Basic information

Product Name: 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester
Synonyms: 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester
CAS NO:254745-48-7
Molecular Formula:
Molecular Weight: 365.183
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester(254745-48-7)
EPA Substance Registry System: 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester(254745-48-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 254745-48-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

254745-48-7 Suppliers

Recommended suppliers

254745-48-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 254745-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,4,7,4 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 254745-48:
(8*2)+(7*5)+(6*4)+(5*7)+(4*4)+(3*5)+(2*4)+(1*8)=157
157 % 10 = 7
So 254745-48-7 is a valid CAS Registry Number.

254745-48-7Upstream product

254745-48-7Downstream Products

892505-90-7 methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

254745-48-7Relevant academic research and scientific papers

NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS

-

Page/Page column 254, (2010/11/28)

The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.

METHOD FOR PRODUCTION OF CANDESARTAN

-

Page/Page column 20-21, (2010/11/08)

The invention relates to novel methods for the production of Candesartan, or a protected form of Candesartan, a Candesartan salt or ester, compounds of application in said method, methods for production thereof, use thereof in said method, a novel polymorph of Candesartan cilexetil, a method for production and use thereof for production of a medicament.

Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

-

, (2008/06/13)

Novel biphenyl sulfonamide compounds which are combined angiotensin and endothelin receptor antagonists are claimed along with methods of using such compounds in the treatment of conditions such as hypertension and other diseases, as well as pharmaceutica

Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

-

, (2008/06/13)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 254745-48-7